Legacy Healthcare
Developing safer drugs to treat autoimmune and inflammatory diseases in fragile patients
Developing safer drugs to treat autoimmune and inflammatory diseases in fragile patients
Legacy Healthcare is a Swiss-based biopharmaceutical company focused on leveraging the pleiotropic activity and strong safety profile of plants to develop prescription botanical drugs that address serious medical conditions. Our first product candidate, CINAINU, has demonstrated strong safety and efficacy in patients suffering from alopecia areata, a chronic autoimmune condition with highly damaging psycho-social issues that impact all who suffer from it, especially children.
There is no investment information
No recent news or press coverage available for Legacy Healthcare .
We care about your data, and we'd love to use cookies make your experience better.